4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-042653
EVP, Research & CSO sold 7,900 shares at $48.85 ($385,876)
- EVP, Research & CSO acquired 7,900 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-07-14 | Option exercise | +7,900 | $1.53 | $12,087 | 7,900 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-07-14 | Sale | −7,900 | $48.85 | $385,876 | 0 | D: show line 2 in the form |
| Open-market sales · 7,900 sh · avg $48.85 · $385,876 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-07-14 | Option exercise · Stock Option (Right to Buy) | −7,900 | 516,055 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…